WHO Approves U.S. Pharmaceutical Company's M-Fox Diagnostics for First Emergency

Amid the spread of M-Fox around Africa, the World Health Organization and WHO urgently approved a test method that can quickly diagnose whether M-Fox has been infected, AFP reported.

The WHO said it approved the M.Fox in vitro diagnostic test on the 4th local time in accordance with the emergency use list procedure.

This test method was developed by Abbott Molecular, an American bio company, and is a method of identifying the virus with real-time gene amplification technology after contacting a cotton swab with skin blisters of suspected M.Fox patients.

The WHO evaluated that it was designed to be tested by experienced healthcare workers and that test results could be obtained quickly and accurately.

This is the first time that the WHO has urgently approved an M.Fox diagnostic test.

The WHO added that it is discussing further emergency approval for diagnostic tests and diagnostic devices, while also ensuring that approved products can be quickly supplied to areas with M.Fox outbreaks.